Wedbush Upgrades Nu Skin To Outperform
According to Wedbush, Nu Skin Enterprises (NYSE: NUS) price target is raised to $48.
Wedbush said that it is upgrading NUS to Outperform. “Given potential multiple expansion as expected success of major upcoming product launches should further solidify Nu Skin's reputation as a successful innovator in the global direct-selling industry, we believe shares of NUS should trade at a 20% premium to the peer group average.”
Nu Skin Enterprises closed yesterday at $41.47.
(c) 2012 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We're Loving
